시장보고서
상품코드
1301426

센트럴 랩 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Central Lab Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 182 Pages | 배송안내 : 2-10일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

센트럴 랩 시장 - 보고서의 범위

TMR의 세계 센트럴 랩 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 센트럴 랩 시장의 수익을 제공합니다. 2017년부터 2031년까지 2023년은 기준 연도, 2031년은 예측 연도로 간주됩니다. 이 보고서는 또한 2023-2031년간 세계 센트럴 랩 시장의 복합 연간 성장률(CAGR%)을 제공합니다.

란다. 랍니다. 이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 분석가들이 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하여 주요 조사 활동의 대부분을 수행했으며, 2차 조사에서는 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조를 통해 센트럴 랩 시장을 파악했습니다.

이 보고서는 세계 센트럴 랩 시장 경쟁 구도를 자세히 분석합니다. 세계 센트럴 랩 시장에서 활동하는 주요 기업이 식별되며, 이들 각각은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 제시된 세계 센트럴 랩 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계 시장 분석과 예측, 2017-2031년

제5장 주요 인사이트

  • 주요 기업 3사가 채택한 전략
  • 세포 및 유전자 치료가 시장에 미치는 영향
  • 임상시험이 시장에 미치는 영향
  • COVID-19의 영향 분석

제6장 세계 시장 분석과 예측 : 제품별

  • 서론과 정의
  • 주요 발견과 개발
  • 제품별 시장 매출 예측, 2017-2031년
    • 유전 서비스
    • 바이오마커 서비스
    • 미생물학 서비스
    • 해부 병리학/조직학
    • 검체 관리 및 보관
    • 특수화학 서비스
    • 임상연구 및 임상시험 서비스
    • 기타
  • 제품별 시장 매력도

제7장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 발견과 개발
  • 최종사용자별 시장 매출 예측, 2017-2031년
    • 제약회사
    • 바이오테크놀러지 기업
    • 학술연구기관
  • 최종사용자별 시장 매력도

제8장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 지역별 매출 예측
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 국가 및 지역별 시장의 매력

제9장 북미 시장 분석과 예측

제10장 유럽 시장 분석과 예측

제11장 아시아태평양 시장 분석과 예측

제12장 라틴아메리카 시장 분석과 예측

제13장 중동 및 아프리카 시장 분석과 예측

제14장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
  • 기업별 시장 점유율 분석(2022)
  • 기업 개요
    • ACM Global Laboratories
    • Barc Lab(Cerba Research)
    • Bioscientia(Sonic Healthcare)
    • Celerion
    • CIRION BioPharma Research
    • Clinical Reference Laboratory
    • Eurofins oratory
    • Frontage Laboratories, Inc.
    • ICON oratories
    • INTERLAB Services
    • InVitro International
    • Labcorp/Covance
    • LabConnect
    • Medpace
    • MLM Medical Labs GmbH
    • PPD
    • Q2 Solutions
LSH 23.07.13

Central Lab Market - Scope of Report

TMR's report on the global Central Lab market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Central Lab market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Central Lab market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Central Lab market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Central Lab market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Central Lab market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Central Lab market.

The report delves into the competitive landscape of the global Central Lab market. Key players operating in the global Central Lab market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Central Lab market profiled in this report.

Key Questions Answered in Global Central Lab Market Report:

  • What is the sales/revenue generated by Central Lab across all regions during the forecast period?
  • What are the opportunities in the global Central Lab market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Central Lab Market - Research Objectives and Research Approach

The comprehensive report on the global Central Lab market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Central Lab market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Central Lab market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Central Lab Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Central Lab Market Analysis and Forecast, 2017 - 2031

5. Key Insights

  • 5.1. Strategies Adopted by Top 3 Players
  • 5.2. Impact of Cell and Gene Therapy on Central Lab Market
  • 5.3. Impact of Clinical Trial on Central Lab Market
  • 5.4. COVID-19 Impact Analysis

6. Global Central Lab Market Analysis and Forecast, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2017 - 2031
    • 6.3.1. Genetic Services
    • 6.3.2. Biomarker Services
    • 6.3.3. Microbiology Services
    • 6.3.4. Anatomic Pathology/Histology
    • 6.3.5. Specimen Management & Storage
    • 6.3.6. Special Chemistry Services
    • 6.3.7. Clinical Research & Trial Services
    • 6.3.8. Others
  • 6.4. Market Attractiveness By Product

7. Global Central Lab Market Analysis and Forecast, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By End-user, 2017 - 2031
    • 7.3.1. Pharmaceutical Companies
    • 7.3.2. Biotechnology Companies
    • 7.3.3. Academic & Research Institutes
  • 7.4. Market Attractiveness By End-user

8. Global Central Lab Market Analysis and Forecast, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness By Country/Region

9. North America Central Lab Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Product, 2017 - 2031
    • 9.2.1. Genetic Services
    • 9.2.2. Biomarker Services
    • 9.2.3. Microbiology Services
    • 9.2.4. Anatomic Pathology/Histology
    • 9.2.5. Specimen Management & Storage
    • 9.2.6. Special Chemistry Services
    • 9.2.7. Clinical Research & Trial Services
    • 9.2.8. Others
  • 9.3. Market Value Forecast By End-user, 2017 - 2031
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Biotechnology Companies
    • 9.3.3. Academic & Research Institutes
  • 9.4. Market Value Forecast By Country, 2017 - 2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Central Lab Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2017 - 2031
    • 10.2.1. Genetic Services
    • 10.2.2. Biomarker Services
    • 10.2.3. Microbiology Services
    • 10.2.4. Anatomic Pathology/Histology
    • 10.2.5. Specimen Management & Storage
    • 10.2.6. Special Chemistry Services
    • 10.2.7. Clinical Research & Trial Services
    • 10.2.8. Others
  • 10.3. Market Value Forecast By End-user, 2017 - 2031
    • 10.3.1. Pharmaceutical Companies
    • 10.3.2. Biotechnology Companies
    • 10.3.3. Academic & Research Institutes
  • 10.4. Market Value Forecast By Country, 2017 - 2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country

11. Asia Pacific Central Lab Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2017 - 2031
    • 11.2.1. Genetic Services
    • 11.2.2. Biomarker Services
    • 11.2.3. Microbiology Services
    • 11.2.4. Anatomic Pathology/Histology
    • 11.2.5. Specimen Management & Storage
    • 11.2.6. Special Chemistry Services
    • 11.2.7. Clinical Research & Trial Services
    • 11.2.8. Others
  • 11.3. Market Value Forecast By End-user, 2017 - 2031
    • 11.3.1. Pharmaceutical Companies
    • 11.3.2. Biotechnology Companies
    • 11.3.3. Academic & Research Institutes
  • 11.4. Market Value Forecast By Country, 2017 - 2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country

12. Latin America Central Lab Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2017 - 2031
    • 12.2.1. Genetic Services
    • 12.2.2. Biomarker Services
    • 12.2.3. Microbiology Services
    • 12.2.4. Anatomic Pathology/Histology
    • 12.2.5. Specimen Management & Storage
    • 12.2.6. Special Chemistry Services
    • 12.2.7. Clinical Research & Trial Services
    • 12.2.8. Others
  • 12.3. Market Value Forecast By End-user, 2017 - 2031
    • 12.3.1. Pharmaceutical Companies
    • 12.3.2. Biotechnology Companies
    • 12.3.3. Academic & Research Institutes
  • 12.4. Market Value Forecast By Country, 2017 - 2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country

13. Middle East & Africa Central Lab Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2017 - 2031
    • 13.2.1. Genetic Services
    • 13.2.2. Biomarker Services
    • 13.2.3. Microbiology Services
    • 13.2.4. Anatomic Pathology/Histology
    • 13.2.5. Specimen Management & Storage
    • 13.2.6. Special Chemistry Services
    • 13.2.7. Clinical Research & Trial Services
    • 13.2.8. Others
  • 13.3. Market Value Forecast By End-user, 2017 - 2031
    • 13.3.1. Pharmaceutical Companies
    • 13.3.2. Biotechnology Companies
    • 13.3.3. Academic & Research Institutes
  • 13.4. Market Value Forecast By Country, 2017 - 2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. ACM Global Laboratories
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Test Type Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Barc Lab (Cerba Research)
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Test Type Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Bioscientia (Sonic Healthcare)
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Test Type Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Celerion
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Test Type Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. CIRION BioPharma Research
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Test Type Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Clinical Reference Laboratory
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Test Type Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Eurofins Central Laboratory
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Test Type Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Frontage Laboratories, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Test Type Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. ICON Central Laboratories
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Test Type Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. INTERLAB Central Lab Services
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Test Type Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. InVitro International
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Test Type Portfolio
      • 14.3.11.3. Financial Overview
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. Labcorp/Covance
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Test Type Portfolio
      • 14.3.12.3. Financial Overview
      • 14.3.12.4. SWOT Analysis
      • 14.3.12.5. Strategic Overview
    • 14.3.13. LabConnect
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Test Type Portfolio
      • 14.3.13.3. Financial Overview
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview
    • 14.3.14. Medpace
      • 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.14.2. Test Type Portfolio
      • 14.3.14.3. Financial Overview
      • 14.3.14.4. SWOT Analysis
      • 14.3.14.5. Strategic Overview
    • 14.3.15. MLM Medical Labs GmbH
      • 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.15.2. Test Type Portfolio
      • 14.3.15.3. Financial Overview
      • 14.3.15.4. SWOT Analysis
      • 14.3.15.5. Strategic Overview
    • 14.3.16. PPD
      • 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.16.2. Test Type Portfolio
      • 14.3.16.3. Financial Overview
      • 14.3.16.4. SWOT Analysis
      • 14.3.16.5. Strategic Overview
    • 14.3.17. Q² Solutions
      • 14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.17.2. Test Type Portfolio
      • 14.3.17.3. Financial Overview
      • 14.3.17.4. SWOT Analysis
      • 14.3.17.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제